Rachel Capone, MSHS
Advertisement
Rachel Capone, MSHS, is a regulatory affairs manager, Syner-G BioPharma Group.
Articles by Rachel Capone, MSHS
Advertisement
Latest Updated Articles
Unlocking the Benefits of FDA’s Orphan Drug DesignationPublished: August 22nd 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Barriers to Treatment in Pediatric Myasthenia Gravis: Jonathan Strober, MD
2
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
3
Defining Relapse and Switching Therapies in Multiple Myeloma
4
Evidence for GLP-1 Therapy in MASH
5
